On July 18, GLONGHUI|LEKAI FILM (600135.SH) announced that in order to improve the industrial layout, give full play to the platform advantages of listed companies, and achieve synergies, Lekai Film plans to acquire 100% of the shares of Lekai Optoelectronics through existing capital raising, and Lekai Optoelectronics will become a wholly-owned subsidiary of Lekai Film. After the acquisition is completed, its capital will be increased, and TAC Film 3 #生产线项目建设，通过对TAC膜技术的整合及运用，逐步改变TFT型TAC膜产品严重依赖进口的局面，拓展乐凯胶片业务经营范围，实现高质量发展。 will be implemented as the main focus

Lekai Film plans to acquire 100% of the shares of Lekai Optoelectronics using the original fund-raising project “Medical Imaging Material Production Line Construction Project” to raise supporting funds in 2018. After the acquisition is completed, it plans to save 53.2656 million yuan in capital from the “Medical Imaging Material Production Line Construction Project” of 53.2656 million yuan, raise interest of 24.449 million yuan, and the 2014 non-public stock fund-raising investment project “Solar Cell Backplane Phase IV Production Expansion Project - Production Lines 14, 15” (abbreviation “14, 15” Line” ) Unused capital of 128.894 million yuan, and interest on raised capital of 43.7949 million yuan. A total of 250 million yuan increased the capital of Lekai Optoelectronics and implemented TAC film 3 #生产线项目建设。 mainly using it